FDA Inspection 1060551 — Nuvisan GmbH
The FDA completed an inspection of Nuvisan GmbH on June 8, 2018 in Neu-Ulm. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 8, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Neu-Ulm (Germany)
Additional Details
Bioanalytical BA/BE